Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

AGMBAgomAb Therapeutics NV

Nasdaq · CIK 0002020932
Filer categoryNon-accelerated filer<br>Emerging growth company
Entity typeother
SIC2836 Biological Products, (No Diagnostic Substances)
FY end1231
XBRL facts1

Identity from submissions API

NameAgomAb Therapeutics NV
CIK0002020932
TickersAGMB
ExchangesNasdaq
Entity typeother
CategoryNon-accelerated filer<br>Emerging growth company
SIC2836 Biological Products, (No Diagnostic Substances)
EIN000000000
LEI—
Fiscal year end1231
State of incorporationC9 Belgium
Phone32 3 302 35 30
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • None listed.
Business address
POSTHOFLEI 1/6
ANTWERPEN
2600
Belgium
C9
Mailing address
POSTHOFLEI 1/6
ANTWERPEN
2600
Belgium
C9

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

52 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-19 4 PRIMARY DOCUMENT 0001445826-26-000020 4978
2026-11-16 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000905148-26-004929 005-95508 261561215 34 11671
2026-11-16 4 PRIMARY DOCUMENT 0001445826-26-000019 9491
2026-11-06 4 PRIMARY DOCUMENT 0001445826-26-000018 7990
2026-10-22 4 PRIMARY DOCUMENT 0001445826-26-000015 6483
2026-10-13 6-K FORM 6-K 0001104659-26-115567 001-43098 261457679 34 37558
2026-10-09 4 PRIMARY DOCUMENT 0001445826-26-000014 4973
2026-10-07 4 PRIMARY DOCUMENT 0001445826-26-000013 6379
2026-10-07 4 PRIMARY DOCUMENT 0002119332-26-000001 8162
2026-10-07 4 PRIMARY DOCUMENT 0002120886-26-000001 8049
2026-10-01 6-K FORM 6-K 0001104659-26-112564 001-43098 261428898 34 60883
2026-09-15 4 OWNERSHIP DOCUMENT 0001104659-26-107916 6348
2026-09-15 4 OWNERSHIP DOCUMENT 0001104659-26-107915 6326
2026-09-15 3 OWNERSHIP DOCUMENT 0001104659-26-107914 10004
2026-09-15 3 OWNERSHIP DOCUMENT 0001104659-26-107912 10167
2026-09-14 6-K FORM 6-K 0001104659-26-107500 001-43098 261377514 34 38681
2026-09-11 6-K FORM 6-K 0001104659-26-107117 001-43098 261375118 34 29000
2026-08-10 6-K FORM 6-K 0001104659-26-093390 001-43098 261258677 34 5357703
2026-08-06 6-K 6-K 0001104659-26-091992 001-43098 261248896 34 260460
2026-06-23 6-K FORM 6-K 0001104659-26-076819 001-43098 261111177 34 60801
2026-05-27 6-K FORM 6-K 0001104659-26-066590 001-43098 261022150 34 37258
2026-05-15 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001104659-26-062718 005-95508 26989065 34 12077
2026-05-15 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001172661-26-002216 005-95508 26985171 34 10417
2026-05-06 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001193125-26-207455 005-95508 26945590 34 7487
2026-04-24 6-K FORM 6-K 0001104659-26-048615 001-43098 26894425 34 2880839
2026-04-23 20-F FORM 20-F 0001104659-26-047872 001-43098 26889755 34 20505184 1 1
2026-04-16 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001213900-26-044365 005-95508 26865894 34 20017
2026-03-18 3 OWNERSHIP DOCUMENT 0001104659-26-030839 13432
2026-03-18 3 OWNERSHIP DOCUMENT 0001104659-26-030843 24452
2026-03-18 3 OWNERSHIP DOCUMENT 0001104659-26-030838 13183
2026-03-18 3 OWNERSHIP DOCUMENT 0001104659-26-030840 11490
2026-03-18 3 OWNERSHIP DOCUMENT 0001104659-26-030842 14691
2026-03-18 3 OWNERSHIP DOCUMENT 0001104659-26-030841 15173
2026-03-18 3 OWNERSHIP DOCUMENT 0001104659-26-030835 17281
2026-03-18 3 OWNERSHIP DOCUMENT 0001104659-26-030836 11656
2026-03-18 3 OWNERSHIP DOCUMENT 0001104659-26-030834 16879
2026-03-18 3 OWNERSHIP DOCUMENT 0001104659-26-030833 18096
2026-03-18 3 OWNERSHIP DOCUMENT 0001104659-26-030837 22499
2026-03-11 S-8 FORM S-8 0001104659-26-026472 333-294220 26744546 33 425014 1 1
2026-03-06 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000315066-26-000646 005-95508 26728945 34 11407
2026-03-05 6-K FORM 6-K 0001104659-26-024095 001-43098 26726062 34 130529
2026-02-17 SCHEDULE 13D xslSCHEDULE_13D_X01/primary_doc.xml 0001193125-26-052946 005-95508 26636235 34 138471
2026-02-09 6-K FORM 6-K 0001104659-26-012080 001-43098 26611678 34 177901
2026-02-06 424B4 424B4 0001104659-26-011523 333-292790 26607819 33 7604310
2026-02-05 CERT AGMB_8A_Cert_0002020932.pdf 0001354457-26-000141 001-43098 26601076 34 124821
2026-02-03 8-A12B FORM 8-A12B 0001104659-26-009822 001-43098 26594561 34 19112
2026-01-30 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-000416 333-292790 26585496 33 1814
2026-01-29 F-1/A F-1/A 0001104659-26-007712 333-292790 26574827 33 8663311 1 1
2026-01-16 F-1 F-1 0001104659-26-004558 333-292790 26539714 33 58288782 1 1
2025-12-17 DRS/A filename1.htm 0001104659-25-122109 377-07291 251580228 33 41343155
2025-10-28 DRS/A filename1.htm 0001104659-25-102694 377-07291 251421067 33 6309672
2024-06-20 DRS filename1.htm 0001104659-24-073452 377-07291 241057239 33 7284634

Latest XBRL company facts

One latest value per concept from companyfacts (1 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 34.17M 2025-12-31 2025 FY 20-F 2026-04-23 0001104659-26-047872

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →